Systems biology of antioxidants

Clinical Science

Volumn 123, Issue 3, 2012, Pages 173-192

  Andriantsitohaina, Ramaroson ^a   Duluc, Lucie ^a   GarćIa RodŕIguez, Julio C ^b   Valle, Lizette Gil Del ^c   Guevara Garcia, Mariela ^d   Simard, Gilles ^a   Soleti, Raffaella ^a   Su, Ding Feng ^e   Velasquez Perez, Luis ^f   Wilson, John X ^g   Laher, Ismail ^h  

^a UNIVERSITÉ D'ANGERS   (France)

^b National Center for Animal Breeding (CENPALAB)   (Cuba)

^c INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^d Research and Development Department   (Cuba)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f UNIVERSITY OF HAVANA   (Cuba)

^g UNIVERSITY AT BUFFALO   (United States)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antioxidant; Ataxia; Diabetes; Free radical; Mitochondrion; Sepsis; Stroke

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; DEHYDROASCORBIC ACID; FREE RADICAL; NICOTINAMIDE ADENINE DINUCLEOTIDE; NUCLEIC ACID BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RETINOL; SPINOCEREBELLAR ATAXIA 2 PROTEIN; UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; OXYGEN;

ADIPOCYTE; CAPILLARY FLOW; CELL FUNCTION; CEREBELLAR ATAXIA; ENDOTHELIUM CELL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MEMBRANE POTENTIAL; MITOCHONDRION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONCENTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SENSORY AXONAL NEUROPATHY; SENSORY MOTOR NEUROPATHY; SENSORY NEUROPATHY; SEPSIS; SPINOCEREBELLAR DEGENERATION; STROKE; ANIMAL; BIOLOGICAL MODEL; METABOLISM; SYSTEMS BIOLOGY;

ANIMALS; ANTIOXIDANTS; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; OXYGEN; REACTIVE OXYGEN SPECIES; SYSTEMS BIOLOGY;

EID: 84861541395     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110643     Document Type: Review

References (133)

1. Doughan, A. K., Harrison, D. G. and Dikalov, S. I. (2008) Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102, 488-496
2. Lee, I. M., Cook, N. R., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H. and Buring, J. E. (2005) Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA, J. Am. Med. Assoc. 294, 56-65
3. Tahara, E. B., Navarete, F. D. and Kowaltowski, A. J. (2009) Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radical Biol. Med. 46, 1283-1297
4. Murphy, M. P. (2009) How mitochondria produce reactive oxygen species. Biochem. J. 417, 1-13
5. Koopman, W. J., Nijtmans, L. G., Dieteren, C. E., Roestenberg, P., Valsecchi, F., Smeitink, J. A. and Willems, P. H. (2010) Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid. Redox Signaling 12, 1431-1470
6. Kussmaul, L. and Hirst, J. (2006) The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc. Natl. Acad. Sci. U.S.A. 103, 7607-7612
7. Paradies, G., Petrosillo, G., Pistolese, M., Di Venosa, N., Federici, A. and Ruggiero, F. M. (2004) Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ. Res. 94, 53-59
8. Hirst, J., King, M. S. and Pryde, K. R. (2008) The production of reactive oxygen species by complex I. Biochem. Soc. Trans. 36, 976-980
9. 2 signaling. Antioxid. Redox Signaling 14, 459-468
10. Osyczka, A., Moser, C. C. and Dutton, P. L. (2005) Fixing the Q cycle. Trends Biochem. Sci. 30, 176-182
11. Cape, J. L., Bowman, M. K. and Kramer, D. M. (2005) A semiquinone intermediate generated at the Qo site of the cytochrome bc1 complex: importance for the Q-cycle and superoxide production. Proc. Natl. Acad. Sci. U.S.A. 104, 7887-7892
12. Starkov, A. A., Fiskum, G., Chinopoulos, C., Lorenzo, B. J., Browne, S. E., Patel, M. S. and Beal, M. F. (2004) Mitochondrial α-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 24, 7779-7788
13. Brand, M. D. (2010) The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 45, 466-472
14. Giorgio, M., Migliaccio, E., Orsini, F., Paolucci, D., Moroni, M., Contursi, C., Pelliccia, G., Luzi, L., Minucci, S., Marcaccio, M. et al. (2005) Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122, 221-233
15. Shc protein, oxidative stress, and cardiovascular complications of diabetes: the missing link. J. Mol. Med. 87, 885-891
16. Shishehbor, M. H., Aviles, R. J., Brennan, M. L., Fu, X., Goormastic, M., Pearce, G. L., Gokce, N., Keaney, Jr, J. F., Penn, M. S., Sprecher, D. L. et al. (2003) Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA, J. Am. Med. Assoc. 289, 1675-1680
17. Peluffo, G. and Radi, R. (2007) Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc. Res. 75, 291-302
18. Martinez, M. C. and Andriantsitohaina, R. (2009) Reactive nitrogen species: molecular mechanisms and potential significance in health and disease. Antioxid. Redox Signaling 11, 669-702
19. Hoffman, D. L. and Brookes, P. S. (2009) Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. J. Biol. Chem. 284, 16236-16245
20. Toime, L. J. and Brand, M. D. (2010) Uncoupling protein-3 lowers reactive oxygen species production in isolated mitochondria. Free Radical Biol. Med. 49, 606-611
21. Krauss, S., Zhang, C. Y. and Lowell, B. B. (2005) The mitochondrial uncoupling-protein homologues. Nat. Rev. Mol. Cell Biol. 6, 248-261
22. Talbot, D. A., Lambert, A. J. and Brand, M. D. (2004) Production of endogenous matrix superoxide from mitochondrial complex I leads to activation of uncoupling protein 3. FEBS Lett. 556, 111-115
23. Echtay, K. S., Esteves, T. C., Pakay, J. L., Jekabsons, M. B., Lambert, A. J., Portero-Otín, M., Pamplona, R., Vidal-Puig, A. J., Wang, S., Roebuck, S. J. and Brand, M. D. (2003) A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 22, 4103-4110
24. Distelmaier, F., Koopman, W. J., van den Heuvel, L. P., Rodenburg, R. J., Mayatepek, E., Willems, P. H. and Smeitink, J. A. (2009) Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain 132, 833-842
25. 2+ and ROS. Front. Biosci. 14, 1197-1218
26. Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W. and Sheu, S. S. (2004) Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287, C817-C833
27. Shiva, S. (2010) Mitochondria as metabolizers and targets of nitrite. Nitric Oxide 22, 64-74
28. Peng, T. I. and Jou, M. J. (2010) Oxidative stress caused by mitochondrial calcium overload. Ann N.Y. Acad. Sci. 1201, 183-188
29. Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U. and Schumacker, P (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1, 401-408
30. Duranteau, J., Chandel, N. S., Kulisz, A., Shao, Z. and Schumacker, P. T. (1998) Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J. Biol. Chem. 273, 11619-11624
31. Chua, Y. L., Dufour, E., Dassa, E. P., Rustin, P., Jacobs, H. T., Taylor, C. T. and Hagen, T. (2010) Stabilization of hypoxia-inducible factor-1α protein in hypoxia occurs independently of mitochondrial reactive oxygen species production. J. Biol. Chem. 285, 31277-31284
32. Perry, J. J., Shin, D. S., Getzoff, E. D. and Tainer, J. A. (2010) The structural biochemistry of the superoxide dismutases. Biochim Biophys Acta 1804, 245-262
33. 2: regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid. Redox Signaling 7, 619-626
34. Quintero, M., Colombo, S. L., Godfrey, A. and Moncada, S. (2006) Mitochondria as signaling organelles in the vascular endothelium. Proc. Natl. Acad. Sci. U.S.A. 103, 5379-5384
35. Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C. and Brownlee, M. (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108, 1341-1348
36. Evans, J. L., Goldfine, I. D., Maddux, B. A. and Grodsky, G. M. (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23, 599-622
37. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H. P. et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790
38. Du, X., Matsumura, T., Edelstein, D., Rossetti, L., Zsengellér, Z., Szabó, C. and Brownlee, M. (2003) Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest. 112, 1049-1057
39. Sethi, A. S., Lees, D. M., Douthwaite, J. A., Dawnay, A. B. and Corder, R. (2006) Homocysteine-induced endothelin-1 release is dependent on hyperglycaemia and reactive oxygen species production in bovine aortic endothelial cells. J. Vasc. Res. 43, 175-183
40. Du, X. L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H., Ziyadeh, F., Wu, J. and Brownlee, M. (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. U.S.A. 97, 12222-12226
41. Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E. and Ceriello, A. (2003) Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52, 2795-2804
42. 2 receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51, 198-203
43. Pricci, F., Leto, G., Amadio, L., Iacobini, C., Cordone, S., Catalano, S., Zicari, A., Sorcini, M., Di Mario, U. and Pugliese, G. (2003) Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C. Free Radical Biol. Med. 35, 683-694
44. Schmidt, P., Youhnovski, N., Daiber, A., Balan, A., Arsic, M., Bachschmid, M., Przybylski, M. and Ullrich, V. (2003) Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J. Biol. Chem. 278, 12813-12819
45. Zheng, J. S., Yang, X. Q., Lookingland, K. J., Fink, G. D., Hesslinger, C., Kapatos, G., Kovesdi, I. and Chen, A. F. (2003) Gene transfer of human guanosine 5_-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 108, 1238-1245
46. Widder, J. D., Fraccarollo, D., Galuppo, P., Hansen, J. M., Jones, D. P., Ertl, G. and Bauersachs, J. (2009) Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of thioredoxin 2. Hypertension 54, 338-344
47. Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L., Lewis, W., Harrison, D. G. and Dikalov, S. I. (2010) Therapeutic targeting of mitochondrial superoxide in hypertension. Circ. Res. 107, 106-116
48. Seshiah, P. N., Weber, D. S., Rocic, P., Valppu, L., Taniyama, Y. and Griendling, K. K. (2002) Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res. 91, 406-413
49. Carriere, A., Carmona, M. C., Fernandez, Y., Rigoulet, M., Wenger, R.H., Pénicaud, L. and Casteilla, L. (2004) Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J. Biol. Chem. 279, 40462-40469
50. Lin, J., Bierhaus, A., Bugert, P., Dietrich, N., Feng, Y., Vom Hagen, F., Nawroth, P., Brownlee, M. and Hammes, H. P. (2006) Effect of R-(+)-α-lipoic acid on experimental diabetic retinopathy. Diabetologia 49, 1089-1096
51. Houstis, N., Rosen, E. D. and Lander, E. S. (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-948
52. Chevillotte, E., Giralt, M., Miroux, B., Ricquier, D. and Villarroya, F. (2007) Uncoupling protein-2 controls adiponectin gene expression in adipose tissue through the modulation of reactive oxygen species production. Diabetes 56, 1042-1050
53. Carrière, A., Fernandez, Y., Rigoulet, M., Penicaud, L. and Casteilla, L. (2003) Inhibition of preadipocyte proliferation by mitochondrial reactive oxygen species. FEBS Lett. 550, 163-167
54. Merial, C., Bouloumie, A., Trocheris, V., Lafontan, M. and Galitzky, J. (2000) Nitric oxide-dependent downregulation of adipocyte UCP-2 expression by tumor necrosis factor-α. Am. J. Physiol. Cell Physiol. 279, C1100-C1106
55. Zhou, H., Zhao, J. and Zhang, X. (2009) Inhibition of uncoupling protein 2 by genipin reduces insulin-stimulated glucose uptake in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 486, 88-93
56. Goossens, G. H. (2008) The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol. Behav. 94, 206-218
57. Sun, J., Xu, Y., Deng, H., Sun, S., Dai, Z. and Sun, Y. (2010) Intermittent high glucose exacerbates the aberrant production of adiponectin and resistin through mitochondrial superoxide overproduction in adipocytes. J. Mol. Endocrinol. 44, 179-185
58. Rossmeisl, M., Syrovy, I., Baumruk, F., Flachs, P., Janovska, P. and Kopecky, J. (2000) Decreased fatty acid synthesis due to mitochondrial uncoupling in adipose tissue. FASEB J. 14, 1793-1800
59. Si, Y., Palani, S., Jayaraman, A. and Lee, K. (2007) Effects of forced uncoupling protein 1 expression in 3T3-L1 cells on mitochondrial function and lipid metabolism. J. Lipid Res. 48, 826-836
60. 2+ and lipid metabolism. J. Nutr. Biochem. 14, 219-226
61. Berniakovich, I., Trinei, M., Stendardo, M., Migliaccio, E., Minucci, S., Bernardi, P., Pelicci, P. G. and Giorgio, M. (2008) p66Shc-generated oxidative signal promotes fat accumulation. J. Biol. Chem. 283, 34283-34293
62. Tormos, K. V., Anso, E., Hamanaka, R. B., Eisenbart, J., Joseph, J., Kalyanaraman, B. and Chandel, N. (2011) Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab. 14, 537-544
63. Ristow, M. and Zarse, K. (2010) How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp. Gerontol. 45, 410-418
64. Szeto, H. H. (2008) Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid. Redox Signaling 10, 601-619
65. Barbato, J. C. (2009) Have no fear, MitoQ10 is here. Hypertension 54, 222-223
66. Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A., Murphy, M. P. and Sammut, I. A. (2005) Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 19, 1088-1095
67. Graham, D., Huynh, N. N., Hamilton, C. A., Beattie, E., Smith, R. A., Cochemé, H. M., Murphy, M. P. and Dominiczak, A. F. (2009) Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54, 322-328
68. Smith, R. A. and Murphy, M. P. (2010) Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann. N.Y. Acad. Sci. 1201, 96-103
69. Lowes, D. A., Thottakam, B. M., Webster, N. R., Murphy, M. P. and Galley, H. F. (2008) The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharidepeptidoglycan model of sepsis. Free Radical Biol. Med. 45, 1559-1565
70. -/- mice. Free Radical Biol. Med. 52, 841-849
71. Lim, S., Rashid, M.A., Jang, M., Kim, Y., Won, H., Lee, J., Woo, J. T., Kim, Y. S., Murphy, M. P. andAli, L. (2011) Mitochondria-targeted antioxidants protect pancreatic β-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity. Cell. Physiol .Biochem. 28, 873-886
72. Wani, W. Y., Gudup, S., Sunkaria, A., Bal, A., Singh, P. P., Kandimalla, R. J., Sharma, D. R. and Gill, K. D. (2011) Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain. Neuropharmacology 61, 1193-1201
73. Gane, E. J., Weilert, F., Orr, D.W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A. and Murphy, M. P. (2010) The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int. 30, 1019-1026
74. Zhao, K., Zhao, G. M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W. and Szeto, H. H. (2004) Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitohcondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem. 279, 34682-34690
75. Cho, J., Won, K., Wu, D., Soong, Y., Liu, S., Szeto, H. H. and Hong, M. K. (2007) Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron. Artery Dis. 18, 215-220
76. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 119, 573-581
77. Rocha, M., Hernandez-Mijares, A., Garcia-Malpartida, K., Banuls, C., Bellod, L. and Victor, V. M. (2010) Mitochondria-targeted antioxidant peptides. Curr. Pharm. Des. 16, 3124-3131
78. Srinivasan, V., Pandi-Perumal, S. R., Spence, D.W., Kato, H. and Cardinali, D. P. (2010) Melatonin in septic shock: some recent concepts. J. Crit. Care 25, 656.e1-656.e6
79. Srinivasan, V., Spence, D.W., Pandi-Perumal, S. R., Brown, G. M. and Cardinali, D. P. (2011) Melatonin in mitochondrial dysfunction and related disorders. Int. J. Alzheimers Dis. 2011, 326320
80. Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R. et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit. Care Med. 36, 296-327
81. Wilson, J. X. (2009) Mechanism of action of vitamin C in sepsis: ascorbate modulates redox signaling in endothelium. Biofactors 35, 5-13
82. Christ, F., Gamble, J., Gartside, I. B. and Kox, W. J. (1998) Increased microvascular water permeability in patients with septic shock, assessed with venous congestion plethysmography (VCP). Intensive Care Med. 24, 18-27
83. Fink, M. P. and Evans, T.W. (2002) Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels. Intensive Care Med. 28, 369-375
84. Armour, J., Tyml, K., Lidington, D. and Wilson, J. X. (2001) Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J. Appl. Physiol. 90, 795-803
85. Secor, D., Li, F., Ellis, C. G., Sharpe, M. D., Gross, P. L., Wilson, J. X. and Tyml, K. (2010) Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries. Intensive Care Med. 36, 1928-1934
86. Wu, F., Wilson, J. X. and Tyml, K. (2003) Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R50-R56
87. Wu, F., Wilson, J. X. and Tyml, K. (2004) Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression. Free Radical Biol. Med. 37, 1282-1289
88. Wu, F., Schuster, D. P., Tyml, K. and Wilson, J. X. (2007) Ascorbate inhibits NADPH oxidase subunit p47phox expression in microvascular endothelial cells. Free Radical Biol. Med. 42, 124-131
89. Wu, F., Tyml, K. and Wilson, J. X. (2008) iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells. J. Cell Physiol. 217, 207-214
90. Tyml, K., Li, F. and Wilson, J. X. (2005) Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle. Crit. Care Med. 33, 1823-1828
91. Dubick, M. A., Williams, C., Elgjo, G. I. and Kramer, G. C. (2005) High-dose vitamin C infusion reduces fluid requirements in the resuscitation of burn-injured sheep. Shock 24, 139-144
92. Kumar, P., Shen, Q., Pivetti, C. D., Lee, E. S., Wu, M.H. and Yuan, S. Y. (2009) Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev. Mol. Med. 11, e19
93. Wu, F. and Wilson, J. X. (2009) Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction. Cardiovasc. Res. 81, 38-45
94. Dimmeler, S., Brinkmann, S. and Neugebauer, E. (1995) Endotoxin-induced changes of endothelial cell viability and permeability: protective effect of a 21-aminosteroid. Eur. J. Pharmacol. 287, 257-261
95. Han, M., Pendem, S., The, S. L., Sukumaran, D. K., Wu, F. and Wilson, J. X. (2010) Ascorbate protects endothelial barrier function during septic insult: role of protein phosphatase type 2A. Free Radical Biol. Med. 48, 128-135
96. Jackson, T. S., Xu, A., Vita, J. A. and Keaney, Jr, J. F. (1998) Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ. Res. 83, 916-922
97. Zhou, G., Kamenos, G. C., Pendem, S., Wilson, J. X. and Wu, F. (2012) Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R409-R416
98. Borrelli, E., Roux-Lombard, P., Grau, G. E., Girardin, E., Ricou, B., Dayer, J. and Suter, P. M. (1996) Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit. Care Med. 24, 392-397
99. Luo, M., Fernandez-Estivariz, C., Jones, D. P., Accardi, C. R., Alteheld, B., Bazargan, N., Hao, L., Griffith, D. P., Blumberg, J. B., Galloway, J. R. and Ziegler, T. R. (2008) Depletion of plasma antioxidants in surgical intensive care unit patients requiring parenteral feeding: effects of parenteral nutrition with or without alanyl-glutamine dipeptide supplementation. Nutrition 24, 37-44
100. Nathens, A. B., Neff, M. J., Jurkovich, G. J., Klotz, P., Farver, K., Ruzinski, J. T., Radella, F., Garcia, I. and Maier, R. V. (2002) Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann. Surg. 236, 814-822
101. Tanaka, H., Matsuda, T., Miyagantani, Y., Yukioka, T., Matsuda, H. and Shimazaki, S. (2000) Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study. Arch. Surg. 135, 326-331
102. Padayatty, S. J., Sun, A. Y., Chen, Q., Espey, M. G., Drisko, J. and Levine, M. (2010) Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS ONE 5, e11414
103. Liu, A. J., Ma, X. J., Shen, F.M., Liu, J. G., Chen, H. and Su, D. F. (2007) Arterial baroreflex: a novel target for preventing stroke in rat hypertension. Stroke 38, 1916-1923
104. Sun, M., Zhao, Y., Gu, Y. and Xu, C. (2009) Inhibition of nNOS reduces ischemic cell death through down-regulating calpain and caspase-3 after experimental stroke. Neurochem. Int. 54, 339-346
105. Ji, H., Tan, S., Igarashi, J., Li, H., Derrick, M., Martásek, P., Roman, L. J., Vásquez-Vivar, J., Poulos, T. L. and Silverman, R. B. (2009) Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy. Ann. Neurol. 65, 209-217
106. Mollace, V., Iannone, M., Muscoli, C., Palma, E., Granato, T., Rispoli, V., Nisticò, R., Rotiroti, D. and Salvemini, D. (2003) The role of oxidative stress in paraquat-induced neurotoxicity in rats: protection by non peptidyl superoxide dismutase mimetic. Neurosci. Lett. 335, 163-166
107. Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Glynn, R. J. and Gaziano, J. M. (2008) Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA, J. Am. Med. Assoc. 300, 2123-2133
108. Rautiainen, S., Larsson, S., Virtamo, J. and Wolk, A. (2012) Total antioxidant capacity of diet and risk of stroke: a population-based prospective cohort of women. Stroke 43, 335-340
109. Cherubini, A., Ruggiero, C., Polidori, M. C. and Mecocci, P. (2005) Potential markers of oxidative stress in stroke. Free Radical Biol. Med. 39, 841-852
110. Zhang, X. H., Lei, H., Liu, A. J., Zou, Y. X., Shen, F. M. and Su, D. F. (2011) Increased oxidative stress is responsible for severer cerebral infarction in stroke-prone spontaneously hypertensive rats. CNS Neurosci. Ther. 17, 590-598
111. El Kossi, M. M. and Zakhary, M. M. (2000) Oxidative stress in the context of acute cerebrovascular stroke. Stroke 31, 1889-1892
112. McCulloch, J. and Dewar, D. (2001) A radical approach to stroke therapy. Proc. Natl. Acad. Sci. U.S.A. 98, 10989-10991
113. Schols, L., Bauer, P., Schmidt, T., Schulte, T. and Riess, O. (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 3, 291-304
114. Velázquez, P. L., Santos, F. N., García, Z. R., Paneque, H. M. and Hechevarria, R. R. (2001) Epidemiology of cuban hereditary ataxia. Rev. Neurol. 32, 606-611
115. Velazquez-Perez, L., Rodriguez-Labrada, R., Canales-Ochoa, N., Sanchez-Cruz, G., Fernandez-Ruiz, J., Montero, J. M., Aguilera-Rodríguez, R., Diaz, R., Almaguer-Mederos, L. E. and Truitz, A.P (2010) Progression markers of Spinocerebellar ataxia 2. A twenty years neurophysiological follow up study. J. Neurol. Sci. 290, 22-26
116. Velazquez Perez, L., Almaguer Mederos, L., Santos Falcon, N., Hechavarria, R., Sanchez Cruz, G. and Paneque, H. M. (2001) Spinocerebellar ataxia type 2 in Cuba. A study of the electrophysiological phenotype and its correlation with clinical and molecular variables. Rev. Neurol. 33, 1129-1136
117. Lastres-Becker, I., Rub, U. and Auburger, G. (2008) Spinocerebellar ataxia 2 (SCA2). Cerebellum 7, 115-124
118. Velazquez-Perez, L., Seifried, C., Santos-Falcon, N., Abele, M., Ziemann, U., Almaguer, L. E., Martínez-Góngora, E., Sánchez-Cruz, G., Canales, N., Pérez-González, R. et al. (2004) Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2. Ann. Neurol. 56, 444-447
119. Sahnoun, Z., Jamoussi, K. and Zeghal, K. M. (1997) Free radicals and antioxidants: human physiology, pathology and therapeutic aspects. Therapie 52, 251-270
120. Casetta, I., Govoni, V. and Granieri, E. (2005) Oxidative stress, antioxidants and neurodegenerative diseases. Curr. Pharm. Des. 11, 2033-2052
121. Pandolfo, M. (2008) Drug Insight: antioxidant therapy in inherited ataxias. Nat. Clin. Pract. Neurol. 4, 86-96
122. Boveris, A. (1998) Biochemistry of free radicals: from electrons to tissues. Medicina 58, 350-356
123. Southorn, P. A. and Powis, G. (1988) Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin. Proc. 63, 381-389
124. Memisogullari, R., Taysi, S., Bakan, E. and Capoglu, I. (2003) Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell. Biochem. Funct. 21, 291-296
125. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M. and Telser, J. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44-84
126. de Zwart, L. L., Meerman, J. H., Commandeur, J. N. and Vermeulen, N. P. (1999) Biomarkers of free radical damage applications in experimental animals and in humans. Free Radical Biol. Med. 26, 202-226
127. Shackelford, R. E., Fu, Y., Manuszak, R. P., Brooks, T. C., Sequeira, A. P., Wang, S., Lowery-Nordberg, M. and Chen, A. (2006) Iron chelators reduce chromosomal breaks in ataxia-telangiectasia cells. DNA Repair 5, 1327-1336
128. Yokota, T., Igarashi, K., Uchihara, T., Jishage, K., Tomita, H., Inaba, A., Li, Y., Arita, M., Suzuki, H., Mizusawa, H. and Arai, H. (2001) Delayed-onset ataxia in mice lacking α-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 98, 15185-15190
129. Delanty, N. and Dichter, M. A. (1998) Oxidative injury in the nervous system. Acta Neurol. Scand. 98, 145-153
130. Korshunov, S. S., Skulachev, V. P. and Starkov, A. A. (1997) High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 416, 15-18
131. Grisham, M. B. and McCord, J. M. (1986) Chemistry and cytotoxicity of reactive oxygen metabolites. In Physiology of Oxygen Radicals (Taylor, A. E., Matalon, S. and Ward, P, eds), pp. 1-18, Oxford University Press, Oxford
132. Aksoy, Y., Sanal, O., Metin, A., Tezcan, I., Ersoy, F., Oǧüş, H. and Ozer, N. (2004) Antioxidant enzymes in red blood cells and lymphocytes of ataxia-telangiectasia patients. Turk. J. Pediatr. 46, 204-207
133. Lukic-Panin, V., Kamiya, T., Zhang, H., Hayashi, T., Tsuchiya, A., Sehara, Y., Deguchi, K., Yamashita, T. and Abe, K. (2007) Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats. Brain Res. 1176, 143-150